ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 736104 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 736104; 2) Community: the network communities that were significantly associated with the response to NSC 736104; 3) Molecule: the relationships between components within communities and NSC 736104; 4) MDR: the compounds that were significantly associated with the NSC 736104.

NSC Compound Enrichment Correlation
NSC 726718 3-(Benzothiazol-6-ylamino)-7-chloro-8-methyl-1,1,-dioxo-4H-1 ,5,2-benzodithiazepin-4-ylideneacetic acid 0.00526022686151168 0.10897442
NSC 727985 NSC 708781 incorporated in micelles, 0.55% (w/w) of drug 0.00526022686151168 -0.060128446
NSC 730460 16-[4-{(3-Imidazol-1-yl)propoxy}-3-methoxybenzylidene]-3b-py rrolidino-5-androsten-17b-YL acetate 0.00526022686151168 -0.076092819
NSC 736793 Null 0.00559873245069072 0.12036924
NSC 743874 Null 0.00559873245069072 -0.0065560133
NSC 750685 Null 0.00559873245069072 0.063136329
NSC 751830 2-(4-hydroxypiperidin-1-yl)-4-(4-morpholinophenylamino)pyrido[4,3-d]pyrimidin-5(6H)-one 0.00559873245069072 -0.14282457
NSC 90810 Null 0.00559873245069072 0.15244146
NSC 135073 WITHACNISTIN 0.00559873245069076 -0.037752785
NSC 144163 Quinoxaline, 6-chloro-2,3-bis(iodomethyl)- 0.00559873245069076 0.12597913
Total:141  Current:28    [First] [Prev] [Next] [Last]